Annals of Hepatology, 2014 Background. Carvedilol appears to be more effective than propranolol in the treatment of portal hypertension in cirrhotic patients.Aim. To compare the effects of carvedilol vs.
Nancy Aguilar-Olivos +6 more
doaj +1 more source
Novel perspectives in redox biology and pathophysiology of failing myocytes: modulation of the intramyocardial redox milieu for therapeutic interventions - A review article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology [PDF]
, 2016 The prevalence of heart failure (HF) is still increasing worldwide, with enormous human, social, and economic costs, in spite of huge efforts in understanding pathogeneticmechanisms and in developing effective therapies that have transformed this ...
Angelini, Annalisa +8 more
core +5 more sources
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Lee M. Bass +22 more
wiley +1 more source
Duplicate Prescription Patterns in Patients With Substance Use Disorders
Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.ABSTRACT This study sought to investigate the frequency and characteristics of duplicate prescriptions (DPs) in psychiatric inpatients with substance use disorders using a DP classification that differentiates between appropriate DPs (ADPs) and potentially inappropriate DPs (PIDPs). The study was conducted as a monocentric retrospective cross‐sectional
Johannes Heck +8 more
wiley +1 more source
What is the most effective beta-blocker for heart failure? [PDF]
, 2003 Three beta-blockers--carvedilol, metoprolol, and bisoprolol--reduce mortality in chronic heart failure caused by left ventricular systolic dysfunction, when used in addition to diuretics and angiotensin converting enzyme (ACE) inhibitors (strength of ...
Neher, Jon O., Safranek, Sarah
core
Improving Postdischarge Outcomes in Acute Heart Failure [PDF]
, 2018 The global burden that acute heart failure (AHF) carries has remained unchanged over the past several decades (1). European registries (2–5) showed that 1-year outcome rates remain unacceptably high (Table 1) and confirm that hospitalization for AHF ...
Ambrosy, Andrew P. +8 more
core +1 more source
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. [PDF]
, 2005 AIMS: We studied the influence of heart rate (HR), systolic blood pressure (SBP), and beta-blocker dose on outcome in the 2599 out of 3029 patients in Carvedilol Or Metoprolol European Trial (COMET) who were alive and on study drug at 4 months after ...
Charlesworth A +11 more
core +1 more source
Clinical Case Reports, Volume 14, Issue 1, January 2026.Transthoracic echocardiography demonstrating biventricular dilatation. Parasternal long‐ and short‐axis views and apical four‐ and two‐chamber views show marked left ventricular dilatation with increased end‐diastolic volume, associated with right ventricular dilatation.
Cristian Orlando Porras Bueno +3 more
wiley +1 more source
Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis.
PLoS ONE, 2014 BackgroundPostoperative atrial fibrillation (POAF) remains the most common complication after cardiac surgery. Current guidelines recommend β-blockers to prevent POAF. Carvedilol is a non-selective β-adrenergic blocker with anti-inflammatory, antioxidant,
Hui-Shan Wang +2 more
doaj +1 more source
Carvedilol: Therapeutic Application and Practice Guidelines [PDF]
, 1998 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90381/1/j.1875-9114.1998.tb03895.x ...
Bleske, Barry E. +2 more
core +1 more source